Press release
Global Anaplastic Astrocytoma Market Comprehensive Study: Forecasted Market Size And Growth Rate | Pfizer Inc., Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd
Anaplastic Astrocytoma Market Growth
The Business Research Company offers in-depth market insights through Anaplastic Astrocytoma Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The anaplastic astrocytoma market size has grown strongly in recent years. It will grow from $6.27 billion in 2023 to $6.62 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to growing adoption of targeted therapies, patient advocacy and awareness, clinical trial expansion, healthcare policy and funding, government initiatives.
The anaplastic astrocytoma market size is expected to see steady growth in the next few years. It will grow to $7.99 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to increasing research and development activities, growing demand for personalized medicine, growing investments, increasing awareness of the disease, increasing stress and depression. Major trends in the forecast period include advancements in neurosurgery, radiation therapy advancements, clinical trials and research, adoption of telemedicine and remote monitoring technologies, advancements in imaging, biotechnology and drug development.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12874&type=smp
Market Segmentation:
The main types of anaplastic astrocytoma disease are Grade I, Grade II, Grade III and Grade IV. Grade I refer to anaplastic astrocytoma tumors that are the least aggressive and are considered benign and treated by surgical excision, routine monitoring and follow-up practices. The treatment options for anaplastic astrocytoma also include surgery, chemotherapy and radiation, categorized into pre-registration and clinical trial phases to be used by hospitals and clinics, retail pharmacies and online pharmacies.
Anaplastic Astrocytoma Global Market Report 2023 provides data on the global anaplastic astrocytoma market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors' revenues, profiles and market shares. The anaplastic astrocytoma market report identifies opportunities and strategies based on market trends and leading competitors' approaches.
Major Driver - Rising Incidence Of Brain Tumors Fuels Growth In The Anaplastic Astrocytoma Market
The growing incidence of primary malignant and non-malignant brain tumors is expected to propel the growth of the anaplastic astrocytoma market. Brain tumors are growths in the brain that can be classified as either cancerous (malignant) and invasive or non-cancerous (benign) and non-invasive, with varying degrees of aggressiveness and potential to spread. The anaplastic astrocytoma treatment removes the tumor and surrounding affected tissue while preserving brain function. For instance, in March 2023, according to the American Society of Clinical Oncology (ASCO), a US-based non-profit organization, approximately 24,810 adults in the United States are expected to receive a diagnosis of primary cancerous tumors originating in the brain and spinal cord, with 14,280 cases among men and 10,530 among women. Therefore, the growing incidence of primary malignant and non-malignant brain tumors will drive the growth of the anaplastic astrocytoma market going forward.
Competitive Landscape:
Major players in the anaplastic astrocytoma market are Pfizer Inc., Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Eisai Co. Ltd., Boehringer Ingelheim International GmbH, Perrigo Company PLC, Ipsen SA, Genentech Inc., Cipla Limited, Novocure Ltd., Celon Laboratories Limited, Avid Bioservices Inc., EirGen Pharma Ltd., Monteris Medical Corporation, GLS Pharma Pvt. Ltd., Tocagen Inc., Pharma's Almanac, Inovio Pharmaceuticals Inc., Isarna Therapeutics GmbH, Actiza Pharmaceutical Private Limited, Celldex Therapeutics Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/anaplastic-astrocytoma-global-market-report
Top Trend - Innovative Approaches In The Anaplastic Astrocytoma Market Boost Enhanced Patient Outcome
Major companies operating in the anaplastic astrocytoma market are innovating novel treatment options to enhance efficacy, minimize side effects and improve patient outcomes. For instance, in June 2022, the U.S. Food and Drug Administration, a US-based federal agency, granted accelerated approval for a novel treatment combination comprising the oral drugs dabrafenib (Tafinlar) and trametinib (Mekinist) for advanced brain tumors with the BRAF V600E mutation. This approval applies to adult and pediatric patients with high- and low-grade gliomas that have progressed after prior treatment. The BRAF V600E mutation is prevalent in various glioma types, including low-grade gliomas, pleomorphic xanthoastrocytomas (PXA), gangliogliomas and pilocytic astrocytoma. The approval was based on clinical trials for the Tafinlar-Mekinist combination therapy that led to tumor shrinkage benefits for both adult and pediatric glioma patients, with a 33% response rate observed in high-grade glioma patients, a 50% response rate in low-grade glioma patients and a 25% response rate in pediatric glioma patients.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Anaplastic Astrocytoma Market Characteristics
3. Anaplastic Astrocytoma Market Trends And Strategies
4. Anaplastic Astrocytoma Market - Macro Economic Scenario
5. Anaplastic Astrocytoma Market Size And Growth
…..
27. Anaplastic Astrocytoma Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Anaplastic Astrocytoma Market Comprehensive Study: Forecasted Market Size And Growth Rate | Pfizer Inc., Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd here
News-ID: 3404941 • Views: …
More Releases from The Business research company
Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancin …
The Integrated Geophysical Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Integrated Geophysical Services Market Size During the Forecast Period?
The integrated geophysical services market has experienced consistent growth in recent years, expected to rise from $2.35 billion in 2024 to…
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, An …
The HR advisory services market report describes and explains the HR advisory services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global HR advisory services market reached a value of nearly $155.74 billion in 2024, having grown at a compound annual growth rate (CAGR) of 4.22% since…
High Voltage Aluminium Electrolytic Capacitors Global Market Report 2025: Size, …
The high voltage aluminum electrolytic capacitors report describes and explains the high voltage aluminum electrolytic capacitors market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global high voltage aluminum electrolytic capacitors market reached a value of nearly $4.10301 billion in 2024, having grown at a compound annual growth…
Global Vertical Market Software Market: Key Trends, Market Share, Growth Drivers …
The vertical market software report describes and explains the vertical market software market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global vertical market software market reached a value of nearly $152.61027 billion in 2024, having grown at a compound annual growth rate (CAGR) of 12.11% since 2019.…
More Releases for Anaplastic
Anaplastic Astrocytoma Market Outlook, Epidemiology, Landscape and Growth Trajec …
Anaplastic astrocytoma (AA) is a rare, malignant brain tumor classified as World Health Organization (WHO) Grade III glioma, characterized by its aggressive nature and poor prognosis. While not as common as glioblastoma, anaplastic astrocytoma represents a significant challenge due to its high recurrence rates, limited treatment options, and resistance to conventional therapies.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70897
Over the past decade, the treatment landscape has slowly evolved…
Anaplastic Large Cell Lymphoma Drugs Market: An In-Depth Analysis
The global Anaplastic Large Cell Lymphoma Drugs market was valued approximately USD 10.5 billion in 2022 and is projected to reach around USD 17.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5% during the forecast period.
Anaplastic Large Cell Lymphoma Drugs Market Overview
Anaplastic Large Cell Lymphoma is a rare type of non-Hodgkin lymphoma characterized by the proliferation of large lymphoid cells. The market for ALCL…
Anaplastic Astrocytoma Market Development, Trends, Segmentations Analysis
Anaplastic astrocytoma is a very rare type of malignant brain tumor affecting human at all ages. As this tumor develops from astrocytes, the star-shaped brain cells it is termed as astrocytoma. The astrocytes along with other cells protect nerve cells in the brain and spinal cord by surrounding them. All these protective cells are collectively termed as glial cells. World Health Organization (WHO) graded these tumors on a scale from…
Anaplastic Astrocytoma - Pipeline Review, H2 2017 - Pharmaceutical Report
Anaplastic astrocytoma is a grade III tumor. It accounts for two percent of all brain tumors. It is a type of glioma that develops from star-shaped glial cells (astrocytes), which support nerve cells. Anaplastic astrocytoma grows faster and more aggressively than grade II astrocytomas. The tumor cells are not uniform in appearance and invade neighboring tissue. Symptoms include headache, weakness, clumsiness, difficulty walking and seizures. Anaplastic astrocytoma is common among…
Anaplastic Oligoastrocytoma Market Snapshot by 2024 – Persistence Market Resea …
Oligoastrocytomas is a part of a group of brain tumor called “gliomas”. Glioma tumor is originated in the brain or spine. Oligoastrocytomas contains both astrocytoma cells and oligodendroglioma. About 2.3% of the brain tumors reported are diagnosed as oligoastrocytomas. Oligoastrocytomas is divided into two parts, low grade and anaplastic. According to the WHO grading system, anaplastic oligoastrocytomas are usually identify as grade 1 and grade 2 but sometimes they appear…
Latest Report Details Of Global Anaplastic Thyroid Cancer Market
Marketresearchreports.biz has added a new research report on the "Anaplastic Thyroid Cancer-Pipeline Insights, 2017" to its collection.
DelveInsights, Anaplastic Thyroid Cancer- Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Anaplastic Thyroid Cancer. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical…
